Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2021 08:32 ET | Source: Novome Biotechnologies, Inc.

Novome Biotechnologies and Genentech Enter into a Strategic Collaboration to Develop Targets Against Inflammatory Bowel Disease

- Collaboration will leverage Novome’s GEMMs platform for colonizing the human gut with therapeutically engineered bacteria - - Novome to receive $15 million upfront payment; potential to receive up...